NCT06406166View on ClinicalTrials.gov

Lifei Xiaoji Wan in Treatment of Advanced NSCLC

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

October 1, 2024

Study Completion Date

December 31, 2024

Conditions
Advanced Non Small Cell Lung Cancer
Interventions
DRUG

Lifei Xiaoji Wan

The Lifei Xiaoji Wan consists of ginseng, blackhead, rhubarb, aster, forehu, and thin on

OTHER

Conventional treatment with Western medicine

Conventional treatment with Western medicine

Trial Locations (1)

450000

RECRUITING

the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou

All Listed Sponsors
lead

Henan University of Traditional Chinese Medicine

OTHER